Gerosynth Laboratories, Inc. — Form D/A
Gerosynth Laboratories, Inc. of Bloomington, MN, a company, filed a Form D amendment with the SEC on 2023-10-18. The offering totals $3.0M, of which $2.7M was reported sold. Industry: Other.
Offering
- Filed: 2023-10-18
- Form: D/A
- Accession: 0001941474-23-000004
- Industry: Other
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.7M
- Remaining: $320K
- Investors: 34
- Date of first sale: 2023-10-18
- Revenue range: Decline to Disclose
- SEC file number: 021-489487
Issuer
- Name: Gerosynth Laboratories, Inc.
- CIK: 0001941474
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 8500 Normandale Lake Blvd., Suite 350, Bloomington, MN, 55437
- Phone: 612.584.3400
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Erin Clark | Director | Bloomington, MN |
| Erin Clark | Executive Officer | Bloomington, MN |
| Brian Hatlevig | Director | Bloomington, MN |
| Bethany Pope | Director | Bloomington, MN |
| Bethany Pope | Executive Officer | Bloomington, MN |
| Alisha O'Dell | Director | Bloomington, MN |
| Alisha O'Dell | Executive Officer | Bloomington, MN |
| Patrick Chuinard | Director | Bloomington, MN |
| Patrick Chuinard | Executive Officer | Bloomington, MN |
| Pat Chuinard | Director | Bloomington, MN |
| Amy Hatlevig | Director | Bloomington, MN |
| Paige Scherer | Director | Bloomington, MN |
| Laurie Chuinard | Director | Bloomington, MN |
Other filings by this issuer (6)
More